OpenURL Connection Search

Select item for more details and to access through your institution.

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 8, p. 1365, doi. 10.1002/alz.12302
By:
- Izzo, Nicholas J.;
- Yuede, Carla M.;
- LaBarbera, Kelsie M.;
- Limegrover, Colleen S.;
- Rehak, Courtney;
- Yurko, Raymond;
- Waybright, Lora;
- Look, Gary;
- Rishton, Gilbert;
- Safferstein, Hank;
- Hamby, Mary E.;
- Williams, Claire;
- Sadlek, Kelsey;
- Edwards, Hannah M.;
- Davis, Charles S.;
- Grundman, Michael;
- Schneider, Lon S.;
- DeKosky, Steven T.;
- Chelsky, Daniel;
- Pike, Ian
Publication type:
Article
Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain‐derived α‐synuclein.
Published in:
Journal of Neuroscience Research, 2021, v. 99, n. 4, p. 1161, doi. 10.1002/jnr.24782
By:
- Limegrover, Colleen S.;
- Yurko, Raymond;
- Izzo, Nicholas J.;
- LaBarbera, Kelsie M.;
- Rehak, Courtney;
- Look, Gary;
- Rishton, Gilbert;
- Safferstein, Hank;
- Catalano, Susan M.
Publication type:
Article
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter.
Published in:
2023
By:
- LaBarbera, Kelsie M.;
- Sheline, Yvette I.;
- Izzo, Nicholas J.;
- Yuede, Carla M.;
- Waybright, Lora;
- Yurko, Raymond;
- Edwards, Hannah M.;
- Gardiner, Woodrow D.;
- Blennow, Kaj;
- Zetterberg, Henrik;
- Börjesson-Hanson, Anne;
- Morgan, Roger;
- Davis, Charles S.;
- Guttendorf, Robert J.;
- Schneider, Lon S.;
- DeKosky, Steven;
- LeVine III, Harry;
- Grundman, Michael;
- Caggiano, Anthony O.;
- Cirrito, John R.
Publication type:
Abstract

Found: 3

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.

Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain‐derived α‐synuclein.

A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter.